Anova-Plus at the heart of the battle against flavescence dorée, a disease that threatens european vineyards.
Anova-Plus, an innovative start-up located on the Genopole campus in Évry, France, is developing a rapid diagnostic test for flavescence dorée, a serious and currently incurable phytoplasmic disease of grapevines. Viticulturists will be able to perform the DNA test themselves and thus quickly identify infected vine stocks. Scheduled for marketing in 2015, the test will help to limit the spread of this quarantine-necessitating disease and improve the use of pesticides.